A2A receptor antagonists block a chemical called adenosine from binding to certain receptors in the body. Istradefylline (Nourianz) is an A2A receptor antagonist used to treat Parkinson's disease symptoms that appear when treatments such as carbidopa/levodopa (Sinemet) wear off.